HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

GV1001 peptide

Subscribe to New Research on GV1001 peptide

Also Known As:

hTERT (611-626)

Networked: 4 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Møller, Mona: 2 articles (11/2011 - 12/2006)
2.	Eriksen, Jon A: 2 articles (11/2011 - 12/2006)
3.	Trachsel, Sissel: 2 articles (11/2011 - 12/2006)
4.	Hunger, Robert E: 2 articles (11/2011 - 05/2011)
5.	Gaudernack, Gustav: 2 articles (11/2011 - 12/2006)
6.	Baek, Seung-Ho: 1 article (01/2015)
7.	Shon, Won-Jun: 1 article (01/2015)
8.	Kwon, Kil-Young: 1 article (01/2015)
9.	Lee, Woo-Cheol: 1 article (01/2015)
10.	Ko, Yoo-Jin: 1 article (01/2015)

Related Diseases

1.	Melanoma (Melanoma, Malignant) 11/01/2011 - "A phase I study was conducted to investigate the safety, tolerability, and immunological responses to vaccination with a combination of telomerase-derived peptides GV1001 (hTERT: 611-626) and p540 (hTERT: 540-548) using granulocyte-macrophage colony-stimulating factor (GM-CSF) or tuberculin as adjuvant in patients with cutaneous melanoma. "
2.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/01/2006 - "A phase I/II study was conducted to investigate the safety, tolerability and clinical response to vaccination with a combination of telomerase peptides GV1001 (hTERT: 611-626) and HR2822 (hTERT: 540-548) in patients with non-small cell lung cancer. "
3.	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 05/01/2011 - "Telomerase-specific GV1001 peptide vaccination fails to induce objective tumor response in patients with cutaneous T cell lymphoma."
4.	Pulpitis 01/01/2015 - "Also, these findings provide mechanistic insight into how GV1001 peptide causes anti-inflammatory actions in LPS-stimulated pulpitis without significantly affecting cell viability. "
5.	Neoplasms (Cancer) 05/01/2011 - "Telomerase-specific GV1001 peptide vaccination fails to induce objective tumor response in patients with cutaneous T cell lymphoma."

Related Drugs and Biologics

1.	Telomerase (Telomerase Reverse Transcriptase)
2.	Peptides
3.	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
4.	Tuberculin (PPD)